HerrickJ. Peculiar elongated and sickle-shaped red blood corpuscles in a case of severe anemia: 1910. Yale J Biol Med. 2001;74:179-184.
2.
OnwubaliliJK. Sickle cell disease and infection. J Infect. 1983;7:2-20.
3.
NarangSFernandezIDChinNLernerNWeinbergGA. Bacteremia in children with sickle hemoglobinopathies. J Pediatr Hematol Oncol. 2012;34:13-16.
4.
Barrett-ConnorE. Bacterial infection and sickle cell anemia. an analysis of 250 infections in 166 patients and a review of the literature. Medicine (Baltimore). 1971;50:97-112.
5.
HalasaNBShankarSMTalbotTR. Incidence of invasive pneumococcal disease among individuals with sickle cell disease before and after the introduction of the pneumococcal conjugate vaccine. Clin Infect Dis. 2007;44:1428-1433.
6.
AdamkiewiczTVSarnaikSBuchananGR. Invasive pneumococcal infections in children with sickle cell disease in the era of penicillin prophylaxis, antibiotic resistance, and 23-valent pneumococcal polysaccharide vaccination. J Pediatr. 2003;143:438-444.
7.
PlattOSBrambillaDJRosseWF. Mortality in sickle cell disease: life expectancy and risk factors for early death. N Engl J Med. 1994;330:1639-1644.
8.
MurphySLXuJKochanekKD. Deaths: preliminary data for 2010. Natl Vital Stat Rep. 2012;60:1-52.
9.
McCavitTLQuinnCTTechasaensiriCRogersZR. Increase in invasive Streptococcus pneumoniae infections in children with sickle cell disease since pneumococcal conjugate vaccine licensure. J Pediatr. 2011;158: 505-507.
10.
BattersbyAJKnox-MacaulayHHCarrolED. Susceptibility to invasive bacterial infections in children with sickle cell disease. Pediatr Blood Cancer. 2010;55:401-406.
11.
AustrianR. The Quellung reaction, a neglected microbiologic technique. Mt Sinai J Med. 1976;43:699-703.
12.
VernacchioLNeufeldEJMacDonaldK. Combined schedule of 7-valent pneumococcal conjugate vaccine followed by 23-valent pneumococcal vaccine in children and young adults with sickle cell disease. J Pediatr. 1998;133:275-278.
13.
HirstCOwusu-OforiS. Prophylactic antibiotics for preventing pneumococcal infection in children with sickle cell disease. Cochrane Database Syst Rev. 2002;(3):CD003427.
14.
EllisonAMOtaKVMcGowanKLSmith-WhitleyK. Pneumococcal bacteremia in a vaccinated pediatric sickle cell disease population. Pediatr Infect Dis J. 2012;31: 534-536.
15.
MufsonMAHaoJBStanekRJNortonNB. Clinical features of patients with recurrent invasive Streptococcus pneumoniae disease. Am J Med Sci. 2012;343:303-309.
16.
MoscosoMGarcíaELópezR. Pneumococcal biofilms. Int Microbiol. 2009;12:77-85.
17.
RestrepoASalazarBAgudeloMRodriguezCZuluagaAVesgaO. Optimization of culture conditions to obtain maximal growth of penicillin-resistantStreptococcus pneumoniae. BMC Microbiol. 2005;5.
18.
StoehrGRoseMEberSHeidemannKSchubertRZielenS. Immunogenicity of sequential pneumococcal vaccination in subjects splenectomised for hereditary spherocytosis. Br J Haematol. 2006;132:788-790.
